- Home
- OTLK vs ANVS Comparison
OTLK vs ANVS Comparison
Compare OTLK & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- ANVS
- Stock Information
- Founded
- OTLK 2010
- ANVS 2008
- Country
- OTLK United States
- ANVS United States
- Employees
- OTLK N/A
- ANVS N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- OTLK Health Care
- ANVS Health Care
- Exchange
- OTLK Nasdaq
- ANVS Nasdaq
- Market Cap
- OTLK N/A
- ANVS 31.2M
- IPO Year
- OTLK 2016
- ANVS 2020
- Fundamental
- Price
- OTLK $1.33
- ANVS $1.31
- Analyst Decision
- OTLK Strong Buy
- ANVS Strong Buy
- Analyst Count
- OTLK 5
- ANVS 5
- Target Price
- OTLK $10.20
- ANVS $37.00
- AVG Volume (30 Days)
- OTLK 441.4K
- ANVS 263.1K
- Earning Date
- OTLK 05-14-2025
- ANVS 05-12-2025
- Dividend Yield
- OTLK N/A
- ANVS N/A
- EPS Growth
- OTLK N/A
- ANVS N/A
- EPS
- OTLK N/A
- ANVS N/A
- Revenue
- OTLK N/A
- ANVS N/A
- Revenue This Year
- OTLK N/A
- ANVS N/A
- Revenue Next Year
- OTLK $288.46
- ANVS N/A
- P/E Ratio
- OTLK N/A
- ANVS N/A
- Revenue Growth
- OTLK N/A
- ANVS N/A
- 52 Week Low
- OTLK $0.87
- ANVS $1.11
- 52 Week High
- OTLK $9.29
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- OTLK 41.00
- ANVS 33.02
- Support Level
- OTLK $1.10
- ANVS $1.11
- Resistance Level
- OTLK $1.31
- ANVS $1.40
- Average True Range (ATR)
- OTLK 0.12
- ANVS 0.17
- MACD
- OTLK 0.01
- ANVS 0.01
- Stochastic Oscillator
- OTLK 42.82
- ANVS 20.83
Stock Price Comparison Chart: OTLK vs ANVS
■ OTLK
■ ANVS
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
Share on Social Networks:
0